Global Hematology Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: GBCC8AD54D42EN
QYResearch

Abstracts

This report focuses on the global Hematology Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Celgene
• Pfizer
• Roche
• Sanof
• Bristol-Myers Squibb
• AbbVie
• Novartis
• GSK
• Johnson & Johnson
• Takeda

Market segment by Type, the product can be split into

• OTC
• Rx Drugs

Market segment by Application, split into

• Hospital
• Drugs Store
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hematology Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hematology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hematology Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hematology Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hematology Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 OTC
  1.4.3 Rx Drugs
1.5 Market by Application
  1.5.1 Global Hematology Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Store
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hematology Treatment Market Perspective (2015-2026)
2.2 Hematology Treatment Growth Trends by Regions
  2.2.1 Hematology Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hematology Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hematology Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hematology Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hematology Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hematology Treatment Players by Market Size
  3.1.1 Global Top Hematology Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hematology Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hematology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hematology Treatment Market Concentration Ratio
  3.2.1 Global Hematology Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hematology Treatment Revenue in 2019
3.3 Hematology Treatment Key Players Head office and Area Served
3.4 Key Players Hematology Treatment Product Solution and Service
3.5 Date of Enter into Hematology Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hematology Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hematology Treatment Forecasted Market Size by Type (2021-2026)

5 HEMATOLOGY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hematology Treatment Market Size by Application (2015-2020)
5.2 Global Hematology Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hematology Treatment Market Size (2015-2020)
6.2 Hematology Treatment Key Players in North America (2019-2020)
6.3 North America Hematology Treatment Market Size by Type (2015-2020)
6.4 North America Hematology Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hematology Treatment Market Size (2015-2020)
7.2 Hematology Treatment Key Players in Europe (2019-2020)
7.3 Europe Hematology Treatment Market Size by Type (2015-2020)
7.4 Europe Hematology Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hematology Treatment Market Size (2015-2020)
8.2 Hematology Treatment Key Players in China (2019-2020)
8.3 China Hematology Treatment Market Size by Type (2015-2020)
8.4 China Hematology Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hematology Treatment Market Size (2015-2020)
9.2 Hematology Treatment Key Players in Japan (2019-2020)
9.3 Japan Hematology Treatment Market Size by Type (2015-2020)
9.4 Japan Hematology Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hematology Treatment Market Size (2015-2020)
10.2 Hematology Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hematology Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hematology Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hematology Treatment Market Size (2015-2020)
11.2 Hematology Treatment Key Players in India (2019-2020)
11.3 India Hematology Treatment Market Size by Type (2015-2020)
11.4 India Hematology Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hematology Treatment Market Size (2015-2020)
12.2 Hematology Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hematology Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hematology Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Celgene
  13.1.1 Celgene Company Details
  13.1.2 Celgene Business Overview and Its Total Revenue
  13.1.3 Celgene Hematology Treatment Introduction
  13.1.4 Celgene Revenue in Hematology Treatment Business (2015-2020))
  13.1.5 Celgene Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Hematology Treatment Introduction
  13.2.4 Pfizer Revenue in Hematology Treatment Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche Hematology Treatment Introduction
  13.3.4 Roche Revenue in Hematology Treatment Business (2015-2020)
  13.3.5 Roche Recent Development
13.4 Sanof
  13.4.1 Sanof Company Details
  13.4.2 Sanof Business Overview and Its Total Revenue
  13.4.3 Sanof Hematology Treatment Introduction
  13.4.4 Sanof Revenue in Hematology Treatment Business (2015-2020)
  13.4.5 Sanof Recent Development
13.5 Bristol-Myers Squibb
  13.5.1 Bristol-Myers Squibb Company Details
  13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.5.3 Bristol-Myers Squibb Hematology Treatment Introduction
  13.5.4 Bristol-Myers Squibb Revenue in Hematology Treatment Business (2015-2020)
  13.5.5 Bristol-Myers Squibb Recent Development
13.6 AbbVie
  13.6.1 AbbVie Company Details
  13.6.2 AbbVie Business Overview and Its Total Revenue
  13.6.3 AbbVie Hematology Treatment Introduction
  13.6.4 AbbVie Revenue in Hematology Treatment Business (2015-2020)
  13.6.5 AbbVie Recent Development
13.7 Novartis
  13.7.1 Novartis Company Details
  13.7.2 Novartis Business Overview and Its Total Revenue
  13.7.3 Novartis Hematology Treatment Introduction
  13.7.4 Novartis Revenue in Hematology Treatment Business (2015-2020)
  13.7.5 Novartis Recent Development
13.8 GSK
  13.8.1 GSK Company Details
  13.8.2 GSK Business Overview and Its Total Revenue
  13.8.3 GSK Hematology Treatment Introduction
  13.8.4 GSK Revenue in Hematology Treatment Business (2015-2020)
  13.8.5 GSK Recent Development
13.9 Johnson & Johnson
  13.9.1 Johnson & Johnson Company Details
  13.9.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.9.3 Johnson & Johnson Hematology Treatment Introduction
  13.9.4 Johnson & Johnson Revenue in Hematology Treatment Business (2015-2020)
  13.9.5 Johnson & Johnson Recent Development
13.10 Takeda
  13.10.1 Takeda Company Details
  13.10.2 Takeda Business Overview and Its Total Revenue
  13.10.3 Takeda Hematology Treatment Introduction
  13.10.4 Takeda Revenue in Hematology Treatment Business (2015-2020)
  13.10.5 Takeda Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hematology Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hematology Treatment Revenue
Table 3. Ranking of Global Top Hematology Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hematology Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of OTC
Table 6. Key Players of Rx Drugs
Table 7. Global Hematology Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hematology Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hematology Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hematology Treatment Market Share by Regions (2015-2020)
Table 11. Global Hematology Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hematology Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hematology Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Hematology Treatment Players
Table 18. Global Hematology Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hematology Treatment Market Share by Players (2015-2020)
Table 20. Global Top Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematology Treatment as of 2019)
Table 21. Global Hematology Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hematology Treatment Product Solution and Service
Table 24. Date of Enter into Hematology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hematology Treatment Market Size Share by Type (2015-2020)
Table 28. Global Hematology Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Hematology Treatment Market Size Share by Application (2015-2020)
Table 30. Global Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hematology Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hematology Treatment Market Share (2019-2020)
Table 34. North America Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hematology Treatment Market Share by Type (2015-2020)
Table 36. North America Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hematology Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hematology Treatment Market Share (2019-2020)
Table 40. Europe Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hematology Treatment Market Share by Type (2015-2020)
Table 42. Europe Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hematology Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hematology Treatment Market Share (2019-2020)
Table 46. China Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Hematology Treatment Market Share by Type (2015-2020)
Table 48. China Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Hematology Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hematology Treatment Market Share (2019-2020)
Table 52. Japan Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hematology Treatment Market Share by Type (2015-2020)
Table 54. Japan Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hematology Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hematology Treatment Market Share (2019-2020)
Table 58. Southeast Asia Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hematology Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hematology Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hematology Treatment Market Share (2019-2020)
Table 64. India Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Hematology Treatment Market Share by Type (2015-2020)
Table 66. India Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Hematology Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hematology Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hematology Treatment Market Share (2019-2020)
Table 70. Central & South America Hematology Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hematology Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Hematology Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hematology Treatment Market Share by Application (2015-2020)
Table 74. Celgene Company Details
Table 75. Celgene Business Overview
Table 76. Celgene Product
Table 77. Celgene Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 78. Celgene Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 88. Roche Recent Development
Table 89. Sanof Company Details
Table 90. Sanof Business Overview
Table 91. Sanof Product
Table 92. Sanof Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 93. Sanof Recent Development
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Product
Table 97. Bristol-Myers Squibb Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Product
Table 102. AbbVie Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 103. AbbVie Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. GSK Business Overview
Table 110. GSK Product
Table 111. GSK Company Details
Table 112. GSK Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 113. GSK Recent Development
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Business Overview
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson Recent Development
Table 119. Takeda Company Details
Table 120. Takeda Business Overview
Table 121. Takeda Product
Table 122. Takeda Revenue in Hematology Treatment Business (2015-2020) (Million US$)
Table 123. Takeda Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hematology Treatment Market Share by Type: 2020 VS 2026
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Hematology Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Hematology Treatment Report Years Considered
Figure 9. Global Hematology Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hematology Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Hematology Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hematology Treatment Market Share by Players in 2019
Figure 14. Global Top Hematology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematology Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hematology Treatment Revenue in 2019
Figure 16. North America Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hematology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Celgene Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 29. Sanof Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sanof Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 31. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bristol-Myers Squibb Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 33. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. AbbVie Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 35. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novartis Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 37. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. GSK Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 39. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Johnson & Johnson Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 41. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takeda Revenue Growth Rate in Hematology Treatment Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed